Bisubstrate analogues as glycosyltransferase inhibitors.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Current Topics in Medicinal Chemistry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2174/156802609787354351PMID 19199998
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Systematic synthesis of bisubstrate-type inhibitors of N-acetylglucosaminyltransferases.

  2006cited by this paper
• Structures and mechanisms of glycosyltransferases.

  2006cited by this paper
• Synthesis of bisubstrate analogues targeting alpha-1,3-fucosyltransferase and their activities.

  2006cited by this paper
• Targeting the forgotten transglycosylases.

  2006cited by this paper
• Synthesis of bisubstrate and donor analogues of sialyltransferase and their inhibitory activities.

  2005cited by this paper
• Bacterial transglycosylase inhibitors.

  2005cited by this paper
• C-glycosides and aza-C-glycosides as potential glycosidase and glycosyltransferase inhibitors.

  2005cited by this paper
• Carbohydrate‐mediated cell adhesion in cancer metastasis and angiogenesis

  2004cited by this paper
• Synthesis of a bisubstrate-type inhibitor of N-acetylglucosaminyltransferases.

  2004cited by this paper
• The design and synthesis of a selective inhibitor of fucosyltransferase VI.

  2004cited by this paper
• Recent development in the design of sialyltransferase inhibitors

  2003cited by this paper
• Design, synthesis and biological evaluation of iminosugar-based glycosyltransferase inhibitors.

  2003cited by this paper
• Potent and specific sialyltransferase inhibitors: imino-linked 5a'-carbadisaccharides.

  2003cited by this paper
• Systematic syntheses and inhibitory activities of bisubstrate-type inhibitors of sialyltransferases.

  2003cited by this paper
• A potent and highly selective inhibitor of human alpha-1,3-fucosyltransferase via click chemistry.

  2003cited by this paper
• Synthesis of GDP-5-thiosugars and their use as glycosyl donor substrates for glycosyltransferases.

  2003cited by this paper
• Efficient sialyltransferase inhibitors based on glycosides of N-acetylglucosamine.

  2002cited by this paper
• The α-Gal epitope (Galα1-3Galβ1-4GlcNAc-R) in xenotransplantation.

  2001cited by this paper
• α(1-3)-Galactosyltransferase Inhibition Based on a New Type of Disubstrate Analogue.

  2001cited by this paper
• Crystal structure of the retaining galactosyltransferase LgtC from Neisseria meningitidis in complex with donor and acceptor sugar analogs

  2001cited by this paper
• Tag-reporter strategy for facile oligosaccharide synthesis on polymer support.

  2001cited by this paper
• Carbohydrate mimetics-based glycosyltransferase inhibitors.

  2001cited by this paper
• Glycosyltransferase structure and mechanism.

  2000cited by this paper
• The C-disaccharide alpha-C(1-->3)-mannopyranoside of N-acetylgalactosamine is an inhibitor of glycohydrolases and of human alpha-1,3-fucosyltransferase VI. Its epimer alpha-(1-->3)-mannopyranoside of N-acetyltalosamine is not.

  2000cited by this paper
• Chemoenzymatic synthesis of L-galactosylated dimeric sialyl Lewis X structures employing alpha-1,3-fucosyltransferase V.

  2000cited by this paper
• Efficient Sialyltransferase Inhibitors Based on Transition-State Analogues of the Sialyl Donor.

  1998cited by this paper
• Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer

  1997cited by this paper
• Selectin-carbohydrate interactions during inflammation and metastasis

  1997cited by this paper
• Novel aspects of interaction between UDP-gal and GlcNAc beta-1,4-galactosyltransferase: transferability and remarkable inhibitory activity of UDP-(mono-O-methylated gal), UDP-Fuc and UDP-man.

  1996cited by this paper
• Transition state and multisubstrate analog inhibitors.

  1995cited by this paper
• Molecular cloning of a cDNA encoding a novel human leukocyte alpha-1,3-fucosyltransferase capable of synthesizing the sialyl Lewis x determinant.

  1994cited by this paper
• Expression cloning of a novel alpha 1,3-fucosyltransferase that is involved in biosynthesis of the sialyl Lewis x carbohydrate determinants in leukocytes.

  1994cited by this paper
• Glycosyltransferases in glycobiology.

  1994cited by this paper
• Biological roles of oligosaccharides: all of the theories are correct

  1993cited by this paper
• Human alpha-1,3 fucosyltransferase (FucT-VI) gene is located at only 13 kb 3' to the Lewis type fucosyltransferase (FucT-III) gene on chromosome 19.

  1993cited by this paper
• Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study.

  1993cited by this paper
• Enzymatic transfer of a preassembled trisaccharide antigen to cell surfaces using a fucosyltransferase.

  1992cited by this paper
• Isolation of a novel human alpha (1,3)fucosyltransferase gene and molecular comparison to the human Lewis blood group alpha (1,3/1,4)fucosyltransferase gene. Syntenic, homologous, nonallelic genes encoding enzymes with distinct acceptor substrate specificities.

  1992cited by this paper
• Molecular cloning of a fourth member of a human alpha (1,3)fucosyltransferase gene family. Multiple homologous sequences that determine expression of the Lewis x, sialyl Lewis x, and difucosyl sialyl Lewis x epitopes.

  1992cited by this paper
• Inhibition of UDP-glucuronosyltransferase activity by possible transition-state analogues in rat-liver microsomes.

  1990cited by this paper
• A bisubstrate analog inhibitor for alpha(1----2)-fucosyltransferase.

  1989cited by this paper
• Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis.

  1987cited by this paper
• Purification to homogeneity of H blood group beta-galactoside alpha 1 leads to 2 fucosyltransferase from porcine submaxillary gland.

  1980cited by this paper
• Tunicamycin, a new antibiotic. I. Isolation and characterization of tunicamycin.

  1971cited by this paper

• Discovery of the selective chemical probe for protein methyltransferase METTL13 by biological evaluation and molecular dynamics simulation.

  2025cites this paper
• MraY: An emerging therapeutic target in bacterial peptidoglycan biosynthesis for the discovery of novel antibiotics from natural and synthetic origin.

  2025cites this paper
• Molecular docking, molecular dynamics simulation, and ADME profiling of novel benzoxazolone-based OGT inhibitors

  2025cites this paper
• Recent advances in the construction of quaternary pseudoanomeric centers in gem-C,C-glycosides: from zaragozic acids to remdesivir.

  2025cites this paper
• Opportunities for Therapeutic Modulation of O-GlcNAc

  2024cites this paper
• Structure-Based Insight on the Mechanism of N-Glycosylation Inhibition by Tunicamycin

  2023cites this paper
• Stereoselective Access to Iminosugar C,C-Glycosides from 6-Azidoketopyranoses.

  2022cites this paper
• Novel bisubstrate uridine-peptide analogues bearing a pyrophosphate bioisostere as inhibitors of human O-GlcNAc transferase.

  2021cites this paper
• Inhibition of Clostridium difficile TcdA and TcdB toxins with transition state analogues

  2021cites this paper
• Chemical Biology Tools for Modulating and Visualizing Gram-Negative Bacterial Surface Polysaccharides.

  2021cites this paper
• Controlling Glycosyltransferase Activity: Inhibition and Enzyme Engineering

  2021cites this paper
• Targeting N‐acetylgalactosaminyltransferase for anticancer therapy

  2020cites this paper
• Bisubstrate Ether‐Linked Uridine‐Peptide Conjugates as O‐GlcNAc Transferase Inhibitors

  2020cites this paper
• Selectins—The Two Dr. Jekyll and Mr. Hyde Faces of Adhesion Molecules—A Review

  2020cites this paper
• N-acetylgalactosaminyltransferase: a potential target for colorectal adenocarcinoma.

  2020cites this paper
• GlcNAc-1-P-transferase-tunicamycin complex structure reveals basis for inhibition of N-glycosylation

  2018cites this paper
• UDP-GlcNAc Analogues as Inhibitors of O-GlcNAc Transferase (OGT): Spectroscopic, Computational, and Biological Studies.

  2018cites this paper
• Structure and mechanism of cancer-associated N-acetylglucosaminyltransferase-V

  2018cites this paper
• Advancement of Sialyltransferase Inhibitors: Therapeutic Challenges and Opportunities

  2017cites this paper
• Synthesis of a β‐d‐Psicofuranosyl Sulfone and Inhibitory‐Activity Evaluation Against N‐Acetylglucosaminyltransferase I

  2017cites this paper
• New Avenues in the Design of Sialyltransferase Inhibitors

  2017cites this paper
• Nucleoside diphosphate sugar analogues that target glycosyltransferases

  2016cites this paper
• Structural insights into inhibition of Lipid I production in bacterial cell wall synthesis

  2016cites this paper
• Three-dimensional homology model of GlcNAc-TV glycosyltransferase.

  2016cites this paper
• Polyphosphate-containing bisubstrate analogues as inhibitors of a bacterial cell wall thymidylyltransferase.

  2015cites this paper
• A practical glycosyltransferase assay for the identification of new inhibitor chemotypes

  2014cites this paper
• Chemical tools to explore nutrient-driven O-GlcNAc cycling

  2014cites this paper
• Beyond substrate analogues: new inhibitor chemotypes for glycosyltransferases

  2014cites this paper
• Synthesis and biological evaluation of neutral glycosyltransferase inhibitors

  2013cites this paper
• Glycosyltransferases as Potential Drug Targets

  2013cites this paper
• Design of glycosyltransferase inhibitors: pyridine as a pyrophosphate surrogate.

  2013cites this paper
• A nonionic inhibitor with high specificity for the UDP-Gal donor binding site of human blood group B galactosyltransferase: design, synthesis, and characterization.

  2013cites this paper
• Bisubstrate UDP–peptide conjugates as human O-GlcNAc transferase inhibitors

  2013cites this paper
• A New Concept for Glycosyltransferase Inhibitors: Nonionic Mimics of the Nucleotide Donor of the Human Blood Group B Galactosyltransferase

  2012cites this paper
• Chemoenzymatic Synthesis of GDP‐L‐Fucose Derivatives as Potent and Selective α‐1,3‐Fucosyltransferase Inhibitors

  2012cites this paper
• Discovery of Inhibitors of Leishmania β-1,2-Mannosyltransferases Using a Click-Chemistry-Derived Guanosine Monophosphate Library

  2012cites this paper
• A Neutral Diphosphate Mimic Crosslinks the Active Site of Human O-GlcNAc Transferase

  2011cites this paper
• NMR-based exploration of the acceptor binding site of human blood group B galactosyltransferase with molecular fragments

  2010cites this paper
• Rational design of FRET-based ratiometric chemosensors for in vitro and in cell fluorescence analyses of nucleoside polyphosphates.

  2010cites this paper
• Duke University Dissertation Template

  2010cites this paper
• Bisubstrate Analogues as Glycosyltransferase Inhibitors

  2009cites this paper
• A survey of chemical methods for sugar-nucleotide synthesis.

  2009cites this paper